A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
News|Articles|July 17, 2026
CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Benjamin P. Saylor
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Advertisement
Thank you for visiting the Contemporary OB/GYN website. Take a look at some of our top stories from the past week (Monday, July 13, to Friday, July 17, 2026) and click on each link to read and watch anything you may have missed.
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Advertisement
Advertisement